On April 08, 2026, the U.S. stock market traded mixed, reflecting a Neutral tone. This breakdown explains what drove the moves and what traders were watching.

Top Market Movers

$COIN — Coinbase Global Inc

Strong crypto market momentum; +1.94% close with elevated insider activity

Bullish case: Bitcoin/crypto adoption accelerating; fintech regulatory clarity improving; insider filings suggest confidence; P/E 39.19 reasonable for growth profile
Bearish case: High short float (11.5%) signals skepticism; crypto volatility remains; regulatory headwinds persist; valuation compression risk if rates stay elevated

Price target: Street target $237.66 (35% upside from current)

$SOFI — SoFi Technologies Inc

Strong +2.65% close; recent 8-K filings (Jan 2026) suggest operational updates; fintech tailwinds

Bullish case: Digital banking penetration growing; student loan refinancing demand rebounding; recent insider activity; lower interest rate environment benefits lending margins
Bearish case: High short float (11.1%) indicates bearish thesis; P/E 41.3 elevated for fintech; recent target cuts signal growth concerns; macro slowdown could hurt loan origination

Price target: Street target $24.77 (52% upside from current $16.27)

$INTC — Intel Corporation

Musk's Terafab partnership announced; +0.79% close; RSI 64.68 (overbought but momentum-driven)

Bullish case: Strategic partnership validates Intel's foundry ambitions; geopolitical push for US chip sovereignty; insider ownership 15.51% (management aligned); AI/defense tailwinds
Bearish case: Negative EPS (-0.08 ttm); execution risk on foundry strategy; competition from TSMC/Samsung; high short float (2.72%); valuation recovery dependent on profitability return

Price target: Street target $51.54 (1.5% upside); momentum play vs. fundamental recovery

$ACIU — AC Immune SA

Biotech screener spike: +15.19% with 607k volume; Alzheimer's/neurodegeneration focus

Bullish case: Potential clinical trial catalyst; biotech sector rotation into small-cap plays; insider filings suggest activity; high-risk/high-reward profile
Bearish case: Micro-cap ($316.5M); binary clinical outcomes; pharma development risk; illiquidity; sector sentiment fragile if rates rise further

Price target: N/A (clinical-stage biotech; no consensus target)

$ACOG — Alpha Cognition Inc

Healthcare screener gainer: +12.26% with 148k volume; AI/cognitive health angle

Bullish case: AI-driven healthcare solutions gaining traction; aging population tailwind; small-cap momentum play; insider interest
Bearish case: Micro-cap ($151.6M); unproven business model; execution risk; sector rotation risk if growth slows

Price target: N/A (early-stage; no consensus target)

→ View the full interactive briefing for April 08, 2026